The estimated Net Worth of Kathleen Goetz is at least $14.3 Thousand dollars as of 9 April 2024. Kathleen Goetz owns over 400 units of abrdn World Healthcare Fund stock worth over $14,289 and over the last 3 years Kathleen sold THW stock worth over $0.
Kathleen has made over 12 trades of the abrdn World Healthcare Fund stock since 2022, according to the Form 4 filled with the SEC. Most recently Kathleen bought 400 units of THW stock worth $5,328 on 9 April 2024.
The largest trade Kathleen's ever made was buying 714 units of abrdn World Healthcare Fund stock on 26 January 2022 worth over $10,424. On average, Kathleen trades about 361 units every 67 days since 2022. As of 9 April 2024 Kathleen still owns at least 1,085 units of abrdn World Healthcare Fund stock.
You can see the complete history of Kathleen Goetz stock trades at the bottom of the page.
Kathleen's mailing address filed with the SEC is C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA, PA, 19103.
Over the last 9 years, insiders at abrdn World Healthcare Fund have traded over $0 worth of abrdn World Healthcare Fund stock and bought 45,572 units worth $663,230 . The most active insiders traders include Daniel R Omstead, Jeffrey Allen Bailey, and Michael W Bonney. On average, abrdn World Healthcare Fund executives and independent directors trade stock every 223 days with the average trade being worth of $40,010. The most recent stock trade was executed by Bill Maher on 14 August 2024, trading 1,000 units of THW stock currently worth $13,030.
tekla life sciences investors is a closed-ended equity mutual fund launched and managed by tekla capital management llc. the fund invests in public equity markets across the globe. it seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. the fund primarily invests in growth stocks of small cap companies. it employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. the fund benchmarks the performance of its portfolio against the nasdaq biotech index and the s&p 500 index. it was form
abrdn World Healthcare Fund executives and other stock owners filed with the SEC include: